| Name | Title | Contact Details |
|---|
Discovery Institute of Medical Education is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ALN provides outsourced business services physician practices across the country. We are helping our customers make tangible and significant improvement in the economic performance of their practice, the amount of time spent by physicians and staff on
Lifespire's Day Treatment facilities provide state of the art therapeutic services for people with severe cognitive and physical challenges. The emphasis of Lifespire's coordinated therapeutic approach is to first assess each person's needs, preferences,
Health Foundation of South Florida is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.